Lv3
220 积分 2021-07-13 加入
Dose Optimization of ClpP Agonists Using an In Vitro Microfluidic Perfusion Platform and In Silico Pharmacokinetic-Pharmacodynamic Modeling
13天前
已完结
Dose Optimization of ClpP Agonists Using an In Vitro Microfluidic Perfusion Platform and In Silico Pharmacokinetic-Pharmacodynamic Modeling
13天前
已完结
Mesenchymal glioma stem cells are maintained by activated glycolytic metabolism involving aldehyde dehydrogenase 1A3
29天前
已完结
Anticancer Effects of Honokiol via Mitochondrial Dysfunction Are Strongly Enhanced by the Mitochondria-Targeting Carrier Berberine
29天前
已完结
Development of submicromolar 17β-HSD10 inhibitors and their in vitro and in vivo evaluation
29天前
已完结
Structure-Guided Design of Pyrazolopyrimidinones as Highly Potent and Selective Allosteric SHP2 Inhibitors
1个月前
已完结
Novel Compounds Targeting the Mitochondrial Protein VDAC1 Inhibit Apoptosis and Protect against Mitochondrial Dysfunction
1个月前
已完结
Discovery of THB Derivates as Ferroptosis Inhibitors for the Treatment of Acute Kidney Injury by Targeting VDAC
1个月前
已关闭
Targeting mitochondrial ClpP: structural insights and therapeutic potential of ClpP agonists in cancer therapy
1个月前
已关闭
Rational Design of Dual Degraders by Incorporating Molecular Glue Structural Features into PROTAC Degraders
1个月前
已完结
皖公网安备34019202002308
